πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 151 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8946444

Tetrahydrocarbazoles as active agents for inhibiting VEGF production by translational cont

PTC THERAPEUTICS, INC. Β· Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8940896

Tetra-cyclic carboline derivatives useful in the inhibition of angiogenesis

PTC THERAPEUTICS, INC. Β· Granted Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8932818

Screening assays for compounds that modulate programmed ribosomal frameshifting

PTC THERAPEUTICS, INC. Β· Granted Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8927576

HCV inhibitor and therapeutic agent combinations

PTC THERAPEUTICS, INC. Β· Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8841302

HCV inhibitor and therapeutic agent combinations

PTC THERAPEUTICS, INC. Β· Granted Tue Sep 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8796322

Methods for using 1,2,4-oxadiazole benzoic acid compounds

PTC THERAPEUTICS, INC. Β· Granted Tue Aug 05 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8748625

Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid

PTC THERAPEUTICS, INC. Β· Granted Tue Jun 10 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8735414

Indole derivatives and methods for antiviral treatment

PTC THERAPEUTICS, INC. Β· Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8716321

Methods for dosing an orally active 1,2,4-oxadiazole

PTC THERAPEUTICS, INC. Β· Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8710031

Compounds for nonsense suppression and methods for their use

PTC THERAPEUTICS, INC. Β· Granted Tue Apr 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8703726

Methods for treating prostate conditions

PTC THERAPEUTICS, INC. Β· Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8697662

Methods for treating Kaposi sarcoma

PTC THERAPEUTICS, INC. Β· Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8691511

Hydroxylated 1,2,4-oxadiazole benzoic acid compounds, compositions thereof and their use i

PTC THERAPEUTICS, INC. Β· Granted Tue Apr 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8680113

BMI-1 protein expression modulators

PTC THERAPEUTICS, INC. Β· Granted Tue Mar 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8633019

Methods for treating spinal muscular atrophy

PTC THERAPEUTICS, INC. Β· Granted Tue Jan 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8486982

1,2,4-oxadiazole benzoic acids

PTC THERAPEUTICS, INC. Β· Granted Tue Jul 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8460864

Methods for identifying compounds that modulate untranslated region-dependent gene express

PTC THERAPEUTICS, INC. Β· Granted Tue Jun 11 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8394966

Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid

PTC THERAPEUTICS, INC. Β· Granted Tue Mar 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8372860

Carboline derivatives useful in the inhibition of angiogenesis

PTC THERAPEUTICS, INC. Β· Granted Tue Feb 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8367841

Processes for the preparation of 1,2,4-oxadiazole benzoic acids

PTC THERAPEUTICS, INC. Β· Granted Tue Feb 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8367694

Carboline derivatives useful in the inhibition of angiogenesis

PTC THERAPEUTICS, INC. Β· Granted Tue Feb 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8334313

Ureido substituted benzoic acid compounds and their use for nonsense suppression and the t

PTC THERAPEUTICS, INC. Β· Granted Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8299105

1,2,4-oxadiazole benzoic acid compositions and their use in bioassays

PTC THERAPEUTICS, INC. Β· Granted Tue Oct 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8278085

RNA processing protein complexes and uses thereof

PTC THERAPEUTICS, INC. Β· Granted Tue Oct 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted